Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

    Home > Events > Esmo conference 2022 european society for medical oncology 2022

    1 min read

    ESMO Congress 2022 - European Society for Medical Oncology

    Meet Veristat at the  ESMO Congress 2022 - European Society for Medical Oncology 2022 taking place on the 9th -13th of September 2022

     

     

    Meet our experienced #Veristat Head of Global Medical Affairs, Atalah Haun, MD, at  ESMO - European Society for Medical Oncology in Paris  September 9 –13.  Don´t miss the opportunity to discuss your clinical program with Veristat. 

     

    With more than 27 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.

    Whether you have a compound and need to get started on your IND, or want to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs - Veristat can help.   

    We provide impactful drug development and regulatory solutions on both a full-service or functional service basis.

     

    Schedule A Meeting

    Schedule a meeting with Atalah Haun, MD  by filling out the form on the right.   Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes.

     

    Conference Details

    Website: https://www.esmo.org/meetings/esmo-congress-2022/registrationhttps://informaconnect.com/bioeurope/

    9th-13th September 2022 , Paris

     

    Veristat Virtual Booth Image

     

     

     

     

    Share This Event:

       

    11 min read

    Monthly FDA Guidance and Regulatory News Review - September 2026

    This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...

    8 min read

    Monthly FDA Guidance and Regulatory News Review - August 2026

    This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...